India's Largest Study On Drug Tocilizumab To Treat Severe Covid Patients

PUBLISHED ON: March 8, 2021 | Duration: 6 min, 06 sec

facebooktwitteremailkoo
loading..
India's first multicentre randomised controlled trial on the use of the drug Tocilizumab in Covid patients has demonstrated that an anti-inflammatory treatment reduces the risk of death among patients with severe COVID-19. The results of the trial were published this morning in one of the world's top journals, 'The Lancet Respiratory Medicine'. We spoke with the lead researcher, Dr Arvinder Singh Soin.
ALSO WATCH
India's Covid Death Count vs WHO's Methodology: What's Not Right?

................................ Advertisement ................................

Short videosBy Firework

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com